Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2018-10-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于子公司获得兽药产品批准文号批件的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining an official approval number for a veterinary drug product. It details regulatory approval, product specifications, and the impact on the company. The document is short (1033 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval event rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-10-29 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policies. It details the reasons for the change, the specific changes made to financial statement line items, and the impact of these changes. It includes opinions from independent directors and the supervisory board endorsing the change. The document does not contain actual financial statements or detailed financial data but rather explains the policy change and its implications. It is not a full annual or interim report, nor is it a certification or a simple notice of report publication. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about accounting policy changes without substantive financial data or a full report attached.
2018-10-25 Chinese
2018年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2018 年第三季度报告' which translates to '2018 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary for the third quarter of 2018. The report is unaudited and covers a period shorter than a full fiscal year (quarterly). The presence of comprehensive financial statements and analysis for the quarter indicates this is an Interim / Quarterly Report. There is no indication that this is an announcement or a summary; the document contains substantive financial data and analysis. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report. 9M 2018
2018-10-25 Chinese
第九届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company 金宇生物技术股份有限公司, specifically the 17th meeting of the 9th board. It includes approval of the company's 2018 third quarter report and a change in accounting policy. The document is short (657 characters) and does not contain the full financial statements or detailed financial data itself, but rather announces the approval of the quarterly report and references another announcement for the accounting policy change. This fits the pattern of a Board/Management Information announcement, as it reports on board decisions and approvals rather than providing the full interim report or financial data. Therefore, the appropriate classification is MANG (Board/Management Information).
2018-10-25 Chinese
独立董事关于公司会计政策变更的独立意见
Regulatory Filings
2018-10-25 Chinese
第九届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board of JinYu Biotechnology Co., Ltd. regarding the review and approval of the company's 2018 third quarter report and a change in accounting policy. It includes statements about the legality and compliance of the report preparation and the meeting procedures. The document is relatively short (887 characters) and serves as a formal announcement of the Supervisory Board's approval rather than the full quarterly report itself. Therefore, it is not the Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) announcing the supervisory board's review and approval of the quarterly report and accounting policy change.
2018-10-25 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.